# FDA Inspection 1181502 - CSL Plasma Inc. - October 07, 2022

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/e166ea94-2cae-40d8-97c2-434fb81e1c81
Source feed: FDA_Inspections

> FDA Inspection 1181502 for CSL Plasma Inc. on October 07, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181502
- Company Name: CSL Plasma Inc.
- Inspection Date: 2022-10-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181502 - 2022-10-07](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/145d0dfd-81f1-4d02-bdf9-956868d58ac2)
- [FDA Inspection 1034000 - 2017-12-06](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/31405361-fdb0-4801-ac05-59dbb1cee72e)

Company: https://www.keypedia.com/companies/csl-plasma-inc/d89ba2ef-a4d5-4fe6-86b0-9fae8791205a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d